ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 110 filers reported holding ALLAKOS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,552,417 | -20.6% | 16,552,417 | 0.0% | 0.46% | -19.0% |
Q1 2024 | $20,856,045 | -10.7% | 16,552,417 | +93.5% | 0.57% | -1.9% |
Q4 2023 | $23,348,098 | +20.3% | 8,552,417 | 0.0% | 0.58% | +11.5% |
Q3 2023 | $19,413,987 | -48.5% | 8,552,417 | -1.2% | 0.52% | -50.1% |
Q2 2023 | $37,724,538 | +39.9% | 8,652,417 | +42.8% | 1.05% | +6.6% |
Q1 2023 | $26,968,099 | -36.0% | 6,060,247 | +21.0% | 0.99% | -44.6% |
Q4 2022 | $42,158,275 | +37.6% | 5,006,921 | 0.0% | 1.78% | +40.5% |
Q3 2022 | $30,642,000 | – | 5,006,921 | – | 1.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 4,887,932 | $517,485,000 | 86.88% |
Fairmount Funds Management LLC | 175,362 | $18,566,000 | 6.75% |
Redmile Group, LLC | 2,131,796 | $225,693,000 | 3.94% |
Samsara BioCapital, LLC | 172,089 | $18,219,000 | 2.86% |
Samsara BioCapital, LLC | 168,200 | $17,807,000 | 2.79% |
NEA Management Company, LLC | 2,164,704 | $229,177,000 | 2.72% |
Ghost Tree Capital, LLC | 85,000 | $8,999,000 | 2.63% |
Sante Capital Fund, LP | 19,258 | $2,039,000 | 1.88% |
Ikarian Capital, LLC | 150,800 | $15,964,000 | 1.12% |
Eventide Asset Management | 630,000 | $66,698,000 | 0.88% |